{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:27:43Z","timestamp":1761920863583,"version":"3.40.5"},"reference-count":79,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Peripheral Nervous Sys"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aims<\/jats:title><jats:p>To develop recommendations for vaccination for coronavirus\u201019 (COVID\u201019) in patients with inflammatory neuropathies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Key questions were formulated in order to perform a literature review on the safety and efficacy of vaccines in patients with inflammatory neuropathies. Based on the best evidence and expert opinion, a list of recommendations was formulated to inform decision on vaccination for COVID\u201019 in patients with inflammatory neuropathies and increase adherence to vaccination programmes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Recommendations addressing safety and efficacy of vaccination in patients with inflammatory neuropathies were formulated. No data are currently available on the safety and efficacy of COVID\u201019 vaccines in patients with inflammatory neuropathies or other immune\u2010mediated conditions. There is only sparse data on the safety of previous available vaccines in patients with inflammatory neuropathies, but studies on other autoimmune disorders indicate that these are safe and mostly efficacious. Patients with inflammatory neuropathies might be at increased risk for severe illness from COVID\u201019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation<\/jats:title><jats:p>Patients with inflammatory neuropathies should be encouraged to adhere to the vaccination campaign for COVID\u201019. These recommendations provide guidance on the management of vaccinations for COVID\u201019 in patients with inflammatory neuropathies. More research is needed regarding the safety and efficacy of vaccination in patients with inflammatory neuropathies and other immune conditions.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jns.12435","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T12:10:23Z","timestamp":1614082223000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acute and chronic inflammatory neuropathies and <scp>COVID<\/scp>\u201019 vaccines: Practical recommendations from the task force of the Italian Peripheral Nervous System Association (<scp>ASNP<\/scp>)"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-6792","authenticated-orcid":false,"given":"Pietro E.","family":"Doneddu","sequence":"first","affiliation":[{"name":"Neuromuscular and Neuroimmunology Service IRCCS Humanitas Research Hospital  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Spina","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Odontostomatology University of Naples \u201cFederico II\u201d  Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-0200","authenticated-orcid":false,"given":"Chiara","family":"Briani","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neuroscience University of Padova  Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-0226","authenticated-orcid":false,"given":"Gian Maria","family":"Fabrizi","sequence":"additional","affiliation":[{"name":"Neurology Unit, Department of Neuroscienze University of Verona, Policlinico Hospital G.B. Rossi  Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9478-3744","authenticated-orcid":false,"given":"Fiore","family":"Manganelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Odontostomatology University of Naples \u201cFederico II\u201d  Naples Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2624-8138","authenticated-orcid":false,"given":"Eduardo","family":"Nobile\u2010Orazio","sequence":"additional","affiliation":[{"name":"Neuromuscular and Neuroimmunology Service IRCCS Humanitas Research Hospital  Milan Italy"},{"name":"Department of Medical Biotechnology and Translational Medicine Milan University  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Italian Peripheral Nervous System Association (ASNP)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20141022-05"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-013-0255-x"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e318285256b"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2004.09306.x"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afm151"},{"key":"e_1_2_15_9_1","article-title":"Guillain\u2010Barr\u00e9 syndrome following influenza vaccines affords opportunity to improve vaccine confidence","volume":"2","author":"Salmon DA","year":"2020","journal-title":"J Infect Dis"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu005"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.013"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.20.2217"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812173392501"},{"issue":"8","key":"e_1_2_15_14_1","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010","volume":"59","author":"Fiore AE","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"e_1_2_15_15_1","first-page":"657","article-title":"Preliminary results: surveillance for Guillain\u2010Barr\u00e9 syndrome after receipt of influenza a (H1N1) 2009 monovalent vaccine \u2010 United States, 2009\u20132010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3220"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws196"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn310"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000344"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301651"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2009.00243.x"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.3.348"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14044"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573397113666170517155443"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(03)00201-4"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.044"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm640"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.026"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12416"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092924"},{"issue":"5","key":"e_1_2_15_31_1","first-page":"819","article-title":"Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis","volume":"58","author":"Zycinska K","year":"2007","journal-title":"J Physiol Pharmacol"},{"issue":"16","key":"e_1_2_15_32_1","first-page":"3217","article-title":"Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"24","author":"Del Porto F","year":"2006","journal-title":"Safety Immunog Vaccine"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30094-3"},{"issue":"7","key":"e_1_2_15_34_1","first-page":"1203","article-title":"Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity","volume":"21","author":"Chalmers A","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.036434"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25033"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440501"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000117358"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2017.13.4.325"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21440"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1446719"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14545"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316715"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.036434"},{"issue":"2","key":"e_1_2_15_46_1","first-page":"317","article-title":"Vaccinations in adults with rheumatoid arthritis in an era of new disease\u2010modifying anti\u2010rheumatic drugs","volume":"36","author":"Meroni PL","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_15_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.109"},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.13.171"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102439"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25034"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.5152\/tpa.2014.2206"},{"key":"e_1_2_15_52_1","unstructured":"https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-1-key-immunization-information\/page-11-blood-products-human-immune-globulin-timing-immunization.html#shr-pg0"},{"key":"e_1_2_15_53_1","unstructured":"https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/a\/mmr_ig.pdf"},{"key":"e_1_2_15_54_1","unstructured":"https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2020\/preparing\u2010international\u2010travelers\/vaccination\u2010and\u2010immunoprophylaxis\u2010general\u2010recommendations"},{"key":"e_1_2_15_55_1","unstructured":"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_000802_041157_RCP.pdf&retry=0&sys=m0b1l3"},{"key":"e_1_2_15_56_1","unstructured":"https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_003822_042804_RCP.pdf&retry=0&sys=m0b1l3"},{"key":"e_1_2_15_57_1","unstructured":"https:\/\/www.cdc.gov\/vaccines\/hcp\/acip\u2010recs\/general\u2010recs\/immunocompetence.htm"},{"issue":"7","key":"e_1_2_15_58_1","first-page":"1","article-title":"Immunization of health\u2010care personnel: recommendations of the advisory committee on immunization practices (ACIP)","volume":"60","author":"Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_15_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00927.x"},{"key":"e_1_2_15_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02579.x"},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/869065"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2016.1214823"},{"key":"e_1_2_15_63_1","unstructured":"https:\/\/www.who.int\/publications\/m\/item\/draft\u2010landscape\u2010of\u2010covid\u201019\u2010candidate\u2010vaccines"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173751"},{"key":"e_1_2_15_65_1","unstructured":"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines-covid-19."},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_2_15_67_1","unstructured":"https:\/\/www.gov.uk\/government\/news\/oxford\u2010universityastrazeneca\u2010covid\u201019\u2010vaccine\u2010approved"},{"key":"e_1_2_15_68_1","unstructured":"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/treatments-vaccines-covid-19-medicines-under-evaluation#covid-19-vaccines-section"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034201"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.011"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026920"},{"issue":"21","key":"e_1_2_15_72_1","first-page":"234","article-title":"Safety and efficacy of an rAd26 and rAd5 vector\u2010based heterologous prime\u2010boost COVID\u201019 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"0140","author":"Logunov DY","year":"2021","journal-title":"Lancet"},{"key":"e_1_2_15_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028436"},{"key":"e_1_2_15_75_1","unstructured":"https:\/\/www.cdc.gov\/coronavirus\/2019\u2010ncov\/vaccines\/recommendations\/underlying\u2010conditions.html"},{"key":"e_1_2_15_76_1","unstructured":"https:\/\/www.aifa.gov.it\/domande-e-risposte-farmacovigilanza-vaccini-covid-19"},{"key":"e_1_2_15_77_1","unstructured":"https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"e_1_2_15_78_1","unstructured":"https:\/\/coronavirus.jhu.edu\/data\/mortality"},{"key":"e_1_2_15_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02957-9"},{"key":"e_1_2_15_80_1","unstructured":"https:\/\/www.cdc.gov\/coronavirus\/2019\u2010ncov\/need\u2010extra\u2010precautions\/people\u2010with\u2010medical\u2010conditions.html"}],"container-title":["Journal of the Peripheral Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jns.12435","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jns.12435","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jns.12435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T08:40:44Z","timestamp":1692866444000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jns.12435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1111\/jns.12435"],"URL":"https:\/\/doi.org\/10.1111\/jns.12435","archive":["Portico"],"relation":{},"ISSN":["1085-9489","1529-8027"],"issn-type":[{"type":"print","value":"1085-9489"},{"type":"electronic","value":"1529-8027"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"2021-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}